Skip to content

NuytsTech Security

  • Home
  • Terms of Use
    • Privacy Policy
  • Blog
  • Cloud Hosting
  • Contact

NuytsTech Security

  • Home
  • Terms of Use
    • Privacy Policy
  • Blog
  • Cloud Hosting
  • Contact
  • Vulnerabilities

CVE-2026-32921

by Fred · 31/03/2026

OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases. Attackers can obtain approval for script execution, modify the approved script file before execution, and execute different content while maintaining the same approved command shape.

More information : https://github.com/openclaw/openclaw/commit/c76d29208bf6a7f058d2cf582519d28069e42240

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Threads (Opens in new window) Threads
  • Share on Mastodon (Opens in new window) Mastodon

Similar

Tags: Cybersecurity Alert

  • Next story CVE-2026-32970
  • Previous story CVE-2026-32920

Recent Posts

  • CVE-2026-5257
  • CVE-2026-5256
  • CVE-2026-5255
  • CVE-2026-2696
  • CVE-2026-5292
  • CVE-2026-5291
  • CVE-2026-5290
  • CVE-2026-5289
  • CVE-2026-5288
  • CVE-2026-5287
  • CVE-2026-5286
  • CVE-2026-5285
  • CVE-2026-5284
  • CVE-2026-5283
  • CVE-2026-5282
  • CVE-2026-5281
  • CVE-2026-5280
  • CVE-2026-5279
  • CVE-2026-5278
  • CVE-2026-5277
  • CVE-2026-5276
  • CVE-2026-5275
  • CVE-2026-5274
  • CVE-2026-5273
  • CVE-2026-5272
  • CVE-2026-5254
  • CVE-2026-5253
  • CVE-2026-5252
  • CVE-2026-5251
  • CVE-2026-5249

Categories

  • Critical cyberalert
  • Vulnerabilities

Tags

CISA Cybersecurity Alert Shields Up

© 1999-2026 NUYTSTECH. All Rights Reserved. Use of the CVE (Common Vulnerabilities and Exposures) from this non-profit website are subject to the terms of use.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.